CLINICAL_TRIALS
trial_result
· 2017-11-20
Clinical Trial Update: Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 [Phase 2]
Summary
Phase 2 trial update for LB1148 in septic shock; study terminated with posted results in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Leading BioSciences, Inc | Conditions: Septic Shock | Phase 2 | Status: TERMINATED | Results posted: 2017-11-20